West Pharmaceutical Services
West Pharmaceutical Services, our mission is to develop and apply proprietary technologies that improve the safety and effectiveness.
Launch date
Employees
Market cap
€19.6b
Enterprise valuation
€19.5b (Public information from Sep 2024)
Share price
$311.20001 WST
Bristol Township Pennsylvania (HQ)
Financials
Estimates*
USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Revenues | 2.1b | 2.8b | 2.9b | 2.9b | 2.9b | 3.1b | 3.4b |
% growth | 17 % | 32 % | 2 % | 2 % | (3 %) | 8 % | 9 % |
EBITDA | 517m | 878m | 855m | 876m | 702m | 861m | 982m |
% EBITDA margin | 24 % | 31 % | 30 % | 30 % | 24 % | 28 % | 29 % |
Profit | 346m | 662m | 586m | 593m | 484m | 599m | 703m |
% profit margin | 16 % | 23 % | 20 % | 20 % | 17 % | 19 % | 21 % |
EV / revenue | 9.8x | 12.3x | 5.8x | 8.6x | 7.7x | 7.1x | 6.4x |
EV / EBITDA | 40.5x | 39.5x | 19.6x | 29.0x | 31.6x | 25.5x | 22.1x |
R&D budget | 46.9m | 52.8m | 58.5m | 68.4m | - | - | - |
R&D % of revenue | 2 % | 2 % | 2 % | 2 % | - | - | - |
Source: Dealroom estimates
Date | Investors | Amount | Round |
---|---|---|---|
N/A | N/A | IPO | |
* | $520k | Post IPO Equity | |
Total Funding | - |
Recent News about West Pharmaceutical Services
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by West Pharmaceutical Services
EditACQUISITION by Viatris May 2016